Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2017	Dec. 31, 2016
Current assets
Cash and cash equivalents (including restricted cash of $18 and $17, respectively)	$ 115	$ 196
Accounts receivable (net of allowance for doubtful accounts of $19 and $17, respectively)	462	390
Inventories:
Finished and in-process goods	221	199
Raw materials and supplies	92	88
Total current assets held for sale	6	0
Other current assets	44	45
Total current assets	940	918
Investments in unconsolidated entities	20	18
Deferred Income Taxes	8	10
Total long-term assets held for sale	2	0
Other assets, net	49	43
Property and equipment
Land	84	79
Buildings	291	273
Machinery and equipment	2,327	2,353
Property, plant and equipment, gross	2,702	2,705
Less accumulated depreciation	(1,778)	(1,812)
Property, plant and equipment, net	924	893
Goodwill	112	121
Other intangible assets, net	42	52
Total assets	2,097	2,055
Current liabilities
Accounts and drafts payable	402	368
Debt payable within one year	125	107
Interest payable	82	70
Income taxes payable	12	13
Accrued payroll and incentive compensation	47	55
Total current liabilities associated with assets held for sale	2	0
Other current liabilities	135	159
Total current liabilities	805	772
Long-term liabilities
Long-term debt	3,584	3,397
Long-term pension and post employment benefit obligations	262	246
Long-term deferred income taxes	11	13
Other long-term liabilities	177	166
Total liabilities	4,839	4,594
Deficit
Common stock—$0.01 par value; 300,000,000 shares authorized, 170,605,906 issued and 82,556,847 outstanding at December 31, 2017 and 2016	1	1
Paid-in capital	526	526
Treasury stock, at cost—88,049,059 shares	(296)	(296)
Accumulated other comprehensive income	(8)	(39)
Accumulated deficit	(2,964)	(2,730)
Total Momentive Specialty Chemicals Inc. shareholder’s deficit	(2,741)	(2,538)
Noncontrolling interest	(1)	(1)
Total deficit	(2,742)	(2,539)
Total liabilities and deficit	$ 2,097	$ 2,055